79 results
SC 13E3/A
EX-99
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Going private transaction (amended)
9:16am
in effect.
“FDA” means the U.S. Food and Drug Administration.
“Financial Expert” means an independent certified public accounting firm of nationally … by an independent public accounting firm selected by Parent and an independent public accounting firm selected by the Acting Holders.
“Net Cash Adjustment
SC 14D9/A
STSA
Satsuma Pharmaceuticals Inc
24 May 23
Tender offer solicitation (amended)
9:40pm
the Company Board Recommendation, the Independent Directors also considered the following factors relating to the procedural safeguards that the Independent … Directors believed were present to ensure fairness of the Offer and the Merger, each of which the Independent Directors believe supported their decision
SC 14D9
STSA
Satsuma Pharmaceuticals Inc
5 May 23
Tender offer solicitation
8:17am
.
At a meeting of the Company Board held on April 16, 2023, seven of the eight Independent Directors (who are identified below) unanimously: (i … are independent for purposes of evaluating a transaction between the Company, on the one hand, and Parent and Purchaser, on the other hand: John
10-K/A
2022 FY
STSA
Satsuma Pharmaceuticals Inc
28 Apr 23
Annual report (amended)
4:08pm
as a member of our Board since September 2017. He has served as an independent biotechnology consultant and advisor since August 2016. Mr. King served … and evaluate our business operations as needed and to
make decisions that are independent of our management. The Corporate Governance Guidelines are also
8-K
EX-2.2
lvkha7xim d99kqw
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-10.1
iqvmxy
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
sxkkwwvnpf ny4l3
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-2.1
j6n7oo
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-1.1
mnlmhcyt62q7 4bv044
3 Nov 22
Entry into a Material Definitive Agreement
4:45pm
424B5
xht 1opbw2u
3 Nov 22
Prospectus supplement for primary offering
4:42pm
8-K
8d2cvig a6t5kmgy8g
7 Jun 22
Submission of Matters to a Vote of Security Holders
6:31am
DEFA14A
yozsevp5jt6bj7g7c 0c
19 Apr 22
Additional proxy soliciting materials
5:40pm
S-8
477dlpcww9v0 lb
16 Mar 22
Registration of securities for employees
4:25pm
S-8
EX-23.1
dvf4lu6pdps3v6btxm4
16 Mar 22
Registration of securities for employees
4:25pm